Tay-Sachs disease with atypical chronic course and limited brain storage: alpha-locus hexosaminidase genetic compound.

Abstract

A 19-year-old Irish-Jewish male had a slow neurologic regression starting at age 4 1/2 years with stuttering. The chronic course resembled that of Spielmeyer-Vogt (juvenile ceroid-lipofuscinosis) disease. The brain was atrophic with neuronal losses and huge compound inclusions in the remaining neurons. Lipid NANA was within normal limits in gray and white matter and GM2 gangliosides were moderately elevated at 11.5% lipid NANA. Beta-hexosaminidase A activity was reduced, secondary to a compound mutation at the alpha-locus. Lysosomal hydrolase activities and lipid composition showed nonspecific abnormalities. Exhaustive tissue extraction ruled out the possibility of tightly bound gangliosides to account for the relatively low GM2 ganglioside concentration. The extract contained unidentified chromogenic substances interfering with the resorcinol reaction. The similarly affected patient's sister lived to age 26 years and her brain was even more atrophic. No biochemical abnormality to account for progressive neuronal losses and relative lack of GM2 ganglioside storage was found.

• Authors: M Philippart, R E Carrel, B H Landing
• Journal: Neurochemical research (Neurochem Res) Vol. 20 Issue 11 Pg. 1323-8 (Nov 1995) ISSN: 0364-3190 [Print] United States
• PMID: 8786818 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• beta-N-Acetylhexosaminidases

Topics

• Adult
• Brain (enzymology, metabolism)
• Chromosome Mapping
• Chronic Disease
• Fatal Outcome
• Humans
• Liver (enzymology)
• Male
• Tay-Sachs Disease (genetics, metabolism)
• beta-N-Acetylhexosaminidases (genetics)